Fortfahren mit
Größe auswählen
| Ihnen/SKU | Verfügbarkeit | Preis |
|---|---|---|
500 mg | Warenkorb auf Verfügbarkeit prüfen | € 407,00 |
Über diesen Artikel
grade
pharmaceutical primary standard
agency
USP
API family
ethosuximide
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
SMILES string
O=C1NC(CC1(C)CC)=O
InChI
1S/C7H11NO2/c1-3-7(2)4-5(9)8-6(7)10/h3-4H2,1-2H3,(H,8,9,10)
InChI key
HAPOVYFOVVWLRS-UHFFFAOYSA-N
Gene Information
human ... CACNA1G(8913), CACNA1H(8912), CACNA1I(8911)
General description
Application
- Ethosuximide Capsules
- Ethosuximide Oral Solution
Analysis Note
Other Notes
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| grade pharmaceutical primary standard | grade pharmaceutical primary standard | grade certified reference material, pharmaceutical secondary standard | grade pharmaceutical primary standard |
| manufacturer/tradename USP | manufacturer/tradename EDQM | manufacturer/tradename - | manufacturer/tradename BP |
| format neat | format neat | format neat | format neat |
| application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) | application(s) pharmaceutical |
| Gene Information human ... CACNA1G(8913), CACNA1H(8912), CACNA1I(8911) | Gene Information human ... CACNA1G(8913), CACNA1H(8912), CACNA1I(8911) | Gene Information human ... CACNA1G(8913), CACNA1H(8912), CACNA1I(8911) | Gene Information human ... CACNA1G(8913), CACNA1H(8912), CACNA1I(8911) |
| storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C |
Still not finding the right product?
Explore all of our products under Ethosuximid
signalword
Warning
hcodes
pcodes
Hazard Classifications
Acute Tox. 4 Oral
Lagerklasse
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

